# Pharmacokinetic Study of Vivitrol in Healthy Participants

> **NCT04716881** · PHASE1 · COMPLETED · sponsor: **Go Medical Industries Pty Ltd** · enrollment: 9 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Naltrexone 380 MG

## Key facts

- **NCT ID:** NCT04716881
- **Lead sponsor:** Go Medical Industries Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-25
- **Primary completion:** 2022-04-04
- **Final completion:** 2022-04-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04716881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04716881, "Pharmacokinetic Study of Vivitrol in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04716881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*